Vaccine Scheduler
Poland: Recommended vaccinations
| General recommendation | |
| Recommendation for specific groups only | |
| Catch-up (e.g. if previous doses missed) | |
| Vaccination not funded by the National Health system | |
| Mandatory vaccination |
| Birth | Months | Years | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2 | 3 | 4 | 5 | 6 | 7 | 13-15 | 16-18 | 6 | 9 | 10 | 14 | 15 | 18 | ||||
| Coronavirus disease (COVID-19) | COVID-193 | ||||||||||||||||
| tuberculosis | BCG4 | ||||||||||||||||
| rotavirus infection | ROTA | ||||||||||||||||
| diphtheria | D | D | D | D | D | d | |||||||||||
| tetanus | TT | TT | TT | TT | TT | TT | |||||||||||
| pertussis | wcP5 | wcP5 | wcP5 | wcP5 | acP | acp | |||||||||||
| poliomyelitis | IPV | IPV | IPV | IPV | IPV | ||||||||||||
| Haemophilus influenzae type b infection | Hib | Hib | Hib | Hib | |||||||||||||
| hepatitis B | HepB4 | HepB | HepB | ||||||||||||||
| pneumococcal disease1 | PCV10 | PCV10 | PCV10 | ||||||||||||||
| meningococcal disease | MenC | MenC | |||||||||||||||
| measles | MEAS | MEAS | MEAS6 | ||||||||||||||
| mumps2 | MUMPS | MUMPS | MUMPS6 | ||||||||||||||
| rubella | RUBE | RUBE | RUBE6 | ||||||||||||||
| varicella | VAR | ||||||||||||||||
| human papillomavirus infection | HPV (F/M)7 | HPV2 (F/M) | |||||||||||||||
| influenza | IIV4 | ||||||||||||||||
Version:
Footnotes:
- Pneumococcal vaccination introduced in the National Immunisation Programme http://www.dziennikustaw.gov.pl/du/2016/1815/1 https://szczepienia.pzh.gov.pl/szczepionki/pneumokoki/?strona=11#czy-mozna-wymiennie-stosowac-%C2%A010--walentna-i-13--walentna-szczepionke-przeciw-pneumokokom-%C2%A0
- More information available at https://szczepienia.pzh.gov.pl/szczepionki/meningokoki/?strona=7#szczepionki-przeciw-meningokokom-w-programie-szczepien-ochronnych
- For detailed information: https://www.gov.pl/web/zdrowie/komunikat-nr-38-ministra-zdrowia-w-sprawie-realizacji-szczepien-przeciw-covid-19-w-sezonie-20252027
- Administration within 24 hours after birth
- An acellular pertussis component (aP) combination vaccine should be used for children with contraindications to vaccination with the whole cell pertussis vaccine and in children born before 37th week of pregnancy or born with birth weight less than 2500 g
- Catch-up for children who did not receive MMR at 10 years of age. An additional dose should be given by 19 years of age
- HPV2/9
More information available at:
https://www.gov.pl/web/zdrowie/program-szczepien-ochronnych-pso- http://dziennikmz.mz.gov.pl/DUM_MZ/2021/85/akt.pdf https://szczepienia.pzh.gov.pl/kalendarz-szczepien-2021/
_________________________________________________________________________
MAJOR HISTORICAL CHANGES
Measles, mumps and rubella:
1975: Measles vaccine was introduced into the national childhood vaccination schedule for children aged 13-15 months.
1989: Rubella vaccine (single dose) was introduced into the national childhood vaccination schedule for 13-year old girls.
1991: Second dose of measles vaccine was introduced into the national childhood vaccination schedule for children aged 7 years.
2003: Monovalent measles vaccine given at the age of 13-15 months was replaced by MMR
2005: Second dose of MMR was introduced into the national childhood vaccination schedule for children aged 10 years. An additional catch-up dose of MMR was provided during 2005-2008 at the age of 12 years for all girls not previously vaccinated at the age of 10 years.
2017: Pneumococcal vaccination introduced in the National Immunisation Programme
2020: Introduction of HPV Vaccine in girls and boys as part of the National Oncological Strategy
_________________________________________________________________________
Date of last update: 15 April 2024
_________________________________________________________________________